Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial.

ABSTRACT:

Background

We conducted a pilot study to assess feasibility of using video directly-observed therapy (DOT) for patients initiating buprenorphine to evaluate whether it is associated with better opioid use disorder (OUD) outcomes when compared to treatment-as-usual (TAU).

Methods

Pilot randomized controlled trial of adult patients with OUD initiating buprenorphine treatment (n = 78) at two sites (Seattle, WA and Boston, MA) from January 2019 to May 2020. Intervention was video DOT using a HIPAA-compliant smartphone application to record taking daily buprenorphine. Study smartphones, text reminders to upload a video, and calendar summaries of video DOT adherence were provided. Main outcomes were 1) percentage of 12 weekly urine drug tests (UDT) negative for illicit opioids and

SUBMITTER: Tsui JI 

PROVIDER: S-EPMC8464515 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature